Fresh analysis suggests that people who stop using new slimming jabs like Wegovy and Mounjaro may regain reduced body mass far faster than those who halt conventional diet and exercise regimens.
Published data in a prominent medical journal demonstrates that while obese people often shed a large proportion of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month after stopping.
"Individuals buying these medications must be cognizant of the potential of fast weight regain when the medication ends," cautioned researcher Dr. Susan Jebb.
This pace of regain suggests a reversion to original weight in about 18 months.
Analyzing Treatments
The analysis, which reviewed dozens of trials involving thousands of participants, contrasted the outcomes of the injectable medications with conventional dieting.
Scientists note that individuals who shed pounds through diet and exercise generally see a slower creep back—perhaps 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Nutrition scientists suggest the mode of action of the injections accounts for the heightened regain.
GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of the hormone levels several times higher than normal might result in the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' leads to hunger is uncontrolled, making excessive eating much more probable."
A Lifelong Issue?
Medical guidelines advise the jabs for individuals with weight-linked health risks, alongside recommended lifestyle changes.
Many experts contend that, given the significant potential of weight regain, the therapy is often long-term.
This view is echoed by pharmaceutical companies, who state that the findings "emphasize the persistent nature of obesity," comparing it to managing diseases like high blood pressure.
Patient Testimonies
Users who have stopped the jabs report a intense return of hunger.
"It felt as if a switch activating and you become extremely hungry," said one woman.
This difficulty is worsened if users have not adopted sustainable dietary or behavioural changes during therapy.
Growing Adoption
Survey data suggest that millions of adults in the UK have used these injections in the past year, with interest being substantial.
- Adoption is higher among women compared to men.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, experts caution that while these medications are potent agents for shedding pounds, they are not a permanent solution and long-term success relies on combined lifestyle management.